In recent years, biotechnologically derived peptide and protein-based drugs have developed into mainstream therapeutic agents. Peptide and protein drugs now constitute a substantial portion of the compounds under preclinical and clinical development in the global pharmaceutical industry. Pharmacokin
Pharmacokinetic aspects of the sublingual administration of vincamine
β Scribed by J-M. Aiache; M-C. Delatte; P-P. Leblanc; J-P. Kantelip; J-L. Steimer
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 713 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
β¦ Synopsis
The sublingual absorption of vincamine used as tracer occurs in two successive absorption steps: true sublingual absorption and absorption in the gastrointestinal tract of the drug dissolved in the saliva and not absorbed through the buccal mucosa. This is confirmed by a pharmacokinetic study and simulation. These two successive absorptions can explain the increase in the amounts of drug absorbed.
π SIMILAR VOLUMES
The systemic bioavailability of the calcium channel blocker verapamil HCl after sublingual (SL) administration has been clinically demonstrated. [1][2][3][4][5] Therefore, this compound was chosen as a model compound for evaluation during establishment of a preclinical rabbit model for intra-oral dr
Ten healthy volunteers received single 2-mg doses of lorazepam on five occasions in random sequence. Modes of administration were: A, intravenous injection; B, deltoid intramuscular injection; C, oral tablets in the fasting state; D, sublingual dosage of oral tablets in the fasting state; and E, sub
In order to examine a potential interaction between isoxicam and propranolol, single 200 mg doses of isoxicam were administered to ten healthy male volunteers before and during treatment with propranolol, gradually attaining a dose of 80 mg t.i.d. for 11 days. The pharmacokinetic profiles of the iso